Basic Information
| LncRNA/CircRNA Name | RP11-19P22.6-001 |
| Synonyms | CPDP1 |
| Region | GRCh38_17:27677805-27678087 |
| Ensemble | ENSG00000264240 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR etc. |
| Sample | gastric cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | RP11-19P22.6-001 expression was significantly downregulated in 70.91% of gastric cancer tissues compared to that of adjacent normal tissues. RP11-19P22.6-001 expression levels were associated with invasion, lymph node metastasis, and TNM stage. |
| Pubmed ID | 28128738 |
| Year | 2017 |
| Title | Clinical significance of the long noncoding RNA RP11-19P22.6-001 in gastric cancer. |
External Links
| Links for RP11-19P22.6-001 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |